| 29.03. | Biontech : Annual Report 2022 |  |
| 28.03. | BioNTech SE : il giorno dopo |  |
| 28.03. | BioNTech SE : El día después |  |
| 28.03. | Some improvement, but let's not get ahead of ourselves | |
| 28.03. | BioNTech Enters New $500 Million Share Repurchase Program | |
| 28.03. | BioNTech SE announces an Equity Buyback for $500 million worth of its shares. | |
| 28.03. | BioNTech Announces New ADS Repurchase Program | |
| 28.03. | BioNTech Announces New ADS Repurchase Program | |
| 28.03. | Analyst recommendations: Barclays, BioNTech, Factset, Marathon P.. | |
| 28.03. | BioNTech SE : Le jour d'après |  |
| 28.03. | BioNTech SE authorizes a Buyback Plan. | |
| 27.03. | Banken herstellen op verdeeld Wall Street |  |
| 27.03. | Wall Street verdeeld | |
| 27.03. | Broad Indexes Mixed as Easing Banking-Sector Stress Lifts Financials; Higher Treasury Y.. | |
| 27.03. | Global markets live: First Citizens, Adidas, Apple, Standard Charter.. | |
| 27.03. | DAX Climbs Amid Positive Business Climate, Mixed Eurozone Lending Data | |
| 27.03. | BioNTech Expects Lower 2023 COVID-19 Vaccine Revenue as Fourth-Quarter Results Drop | |
| 27.03. | Biontech : 2022 Sustainability Report | |
| 27.03. | BioNTech Q4 Earnings, Revenue Decline; Company Sees Lower Fiscal 2023 COVID-19 Vaccine .. | |
| 27.03. | Sector Update: Health Care Stocks Steady Premarket Monday | |
| 27.03. | Wall Street koerst af op hogere opening | |
| 27.03. | BioNTech Plans $500 Million Share Buyback in 2023 | |
| 27.03. | BioNTech meldt teruglopende vraag naar coronavaccins | |
| 27.03. | German Vaccine Maker BioNTech Logs Lower FY22 Attributable Profit | |
| 27.03. | BioNTech Posts Lower 4Q Revenue, Profit; Sees Fall in Covid-Vaccine Sales | |
| 27.03. | BioNTech Q4 Earnings, Revenue Decline | |
| 27.03. | SVB Bank Deal Lifts Wall Street Pre-Bell; Europe Higher, Asia Mixed | |
| 27.03. | Equity Futures Rise Pre-Bell to Build on Late Week Momentum; Asia Mixed, Europe Up | |
| 27.03. | Tranche Update on BioNTech SE's Equity Buyback Plan announced on March 31, 2022. | |
| 27.03. | Biontech : Fourth Quarter and Full Year 2022 Earnings Presentation | |
| 27.03. | BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Up.. | |
| 27.03. | Cash-rich BioNTech plans to spend about $1 bln more on research this year | |
| 27.03. | Futures wijzen op hogere opening Wall Street | |
| 27.03. | Quatre enterrements et un mariage | |
| 27.03. | En Direct des Marchés : Neoen, Elis, Orpea, Equasens, SBV, Unicred.. | |
| 27.03. | Beursagenda: buitenlandse fondsen | |
| 24.03. | Beursagenda: buitenlandse fondsen | |
| 24.03. | Beursagenda: buitenlandse fondsen | |
| 23.03. | Beursagenda: buitenlandse fondsen | |
| 23.03. | Beursagenda: buitenlandse fondsen | |
| 22.03. | Beursagenda: buitenlandse fondsen | |
| 22.03. | China autoriza la primera vacuna con ARNm, de una farmacéutica local | |
| 22.03. | China approves its first mRNA vaccine, from domestic drugmaker CSPC | |
| 22.03. | Beursagenda: buitenlandse fondsen | |
| 21.03. | Beursagenda: buitenlandse fondsen | |
| 21.03. | U.S. FDA to soon decide on second round of Omicron-tailored boosters - WSJ | |
| 21.03. | Moderna: le prix du vaccin anti Covid devrait être de 130 dollars par dose | |
| 21.03. | Beursagenda: buitenlandse fondsen | |
| 20.03. | Moderna expects to price its COVID vaccine at about $130 in the US | |
| 20.03. | BioNTech to jointly develop novel antibody for cancers | |
| 20.03. | Beursagenda: buitenlandse fondsen | |
| 20.03. | BioNTech, OncoC4 to Develop, Commercialize ONC-392 as Therapy in Various Cancer Indicat.. | |
| 20.03. | BioNTech SE and OncoC4, Inc. Announce Strategic Collaboration to Co-Develop and Commerc.. | |
| 20.03. | BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize No.. | |
| 20.03. | BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize No.. | |
| 20.03. | Beursagenda: buitenlandse fondsen | |
| 17.03. | Beursagenda: buitenlandse fondsen | |
| 15.03. | BioNTech, Pfizer Receive Emergency Use Authorization for Bivalent COVID-19 Vaccine in C.. | |
| 15.03. | Pfizer, BioNTech Obtain Emergency Use Authorization for Bivalent COVID-19 Vaccine in Ki.. | |
| 15.03. | Biontech : Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.. | |
| 15.03. | Pfizer Inc. and BioNTech SE Receives U.S. Emergency Use Authorization of Omicron BA.4 B.. | |
| 15.03. | Pfizer : le rappel covid chez les moins de 5 ans autorisé | |
| 15.03. | Rwanda Welcomes Africa's First Mobile Vaccine-Production Units | |
| 15.03. | Pfizer-BioNTech's Omicron-specific COVID-19 Jab Wins US FDA Nod as Booster for Children | |
| 15.03. | U.S. FDA expands authorization of Pfizer bivalent COVID-19 shots in kids | |
| 14.03. | Pfizer agrees to revise EU COVID vaccine contract -FT | |
| 14.03. | Gezondheid en farma: volop aan het consolideren | |
| 14.03. | Dermapharm misses targets - decline in earnings expected in 2023 | |
| 14.03. | Less Corona boost: Dermapharm misses targets - 2023 earnings decline e.. | |
| 13.03. | Financial Stocks Weigh Down European Equities in Monday Trading | |
| 13.03. | Pfizer rachète la biotech Seagen pour 43 milliards de dollars | |
| 13.03. | BioNTech Advances Development of mRNA Vaccine Making Facility in Rwanda | |
| 13.03. | BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational .. | |
| 13.03. | BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational .. | |
| 09.03. | GSK set for US launch of RSV vaccine with no supply issues | |
| 06.03. | Protection From Updated Bivalent COVID-19 Vaccines May Start to Fade After Two Months, .. | |
| 03.03. | Keeping IP Under Lock And Key | |
| 03.03. | Las empresas químicas europeas se muestran pesimistas sobre 2023 | |
| 02.03. | European chemicals firms downbeat on 2023 prospects | |
| 02.03. | Evonik sees lower 2023 profit as prices decline, macro woes persist | |
| 01.03. | Pfizer, BioNTech Apply for US Approval for Omicron Bivalent COVID-19 Vaccine Booster Sh.. | |
| 01.03. | BioNTech to Collaborate With Israel's Weizmann Institute on Disease Research | |
| 01.03. | Biontech : Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of Omicron BA.4.. | |
| 01.03. | Pfizer Inc. and BioNTech SE Submits an Application to the U.S. Emergency Use Authorizat.. | |
| 01.03. | BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct.. | |
| 01.03. | BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct.. | |
| 01.03. | BioNTech SE Announces Establishment of Interdisciplinary MRNA Excellence Center to Cond.. | |
| 01.03. | La defensora del pueblo critica el silencio de Bruselas sobre el contrato de vacunas co.. | |
| 01.03. | Novavax chute de 25% avant l'ouverture de Wall Street, inquiétudes sur ses perspectives | |
| 01.03. | Pfizer, BioNTech Applies for Emergency Use Authorization for COVID Booster Dose for Chi.. | |
| 28.02. | Novavax raises doubts about its ability to remain in business | |
| 27.02. | European Equities Begin Week on Strong Note in Monday Trading | |
| 24.02. | BioNTech, Pfizer File Supplemental Biologics License Application With FDA for Omicron B.. | |
| 24.02. | Pfizer, BioNTech File US FDA Application to Use Omicron-adapted Jab as Primary Series, .. | |
| 24.02. | Biontech : Pfizer and BioNTech Submit Supplemental Biologics License Application for U.S. .. | |
| 24.02. | Pfizer : sollicite la FDA pour son vaccin Covid dès 12 ans | |
| 24.02. | Biontech : Pfizer and BioNTech Submit Supplemental Biologics License Application for U.S. .. | |
| 23.02. | After Strong Start, European Equities Pull Back in Thursday Trading | |
| 21.02. | Health Rounds: Harmful eating behaviors affect 20% of kids | |
| 21.02. | Pharma, Bank Stocks Lead European Equities Modestly Higher in Tuesday Trading | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
